| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |